Impact of the COVID-19 pandemic on treatment patterns for US patients with metastatic solid cancer
View ORCID ProfileRavi B. Parikh, View ORCID ProfileSamuel U. Takvorian, View ORCID ProfileDaniel Vader, View ORCID ProfileE. Paul Wileyto, View ORCID ProfileAmy S. Clark, Daniel J. Lee, View ORCID ProfileGaurav Goyal, View ORCID ProfileGabrielle B. Rocque, View ORCID ProfileEfrat Dotan, View ORCID ProfileDaniel M. Geynisman, View ORCID ProfilePooja Phull, View ORCID ProfilePhilippe E. Spiess, View ORCID ProfileRoger Y. Kim, View ORCID ProfileAmy J. Davidoff, View ORCID ProfileCary P. Gross, Natalia Neparidze, View ORCID ProfileRebecca A. Miksad, View ORCID ProfileGregory S. Calip, View ORCID ProfileCaleb M. Hearn, Will Ferrell, View ORCID ProfileLawrence N. Shulman, View ORCID ProfileRonac Mamtani, View ORCID ProfileRebecca A. Hubbard, for the PRACTICE Investigators
doi: https://doi.org/10.1101/2021.09.22.21263964
Ravi B. Parikh
1Department of Medical Ethics and Health Policy, University of Pennsylvania, Philadelphia, PA USA
MD MPPSamuel U. Takvorian
2Division of Hematology and Oncology, University of Pennsylvania, Philadelphia, PA USA
MD MSHPDaniel Vader
3Department of Biostatistics, Epidemiology, & Informatics, University of Pennsylvania, Philadelphia, PA USA
PhDE. Paul Wileyto
3Department of Biostatistics, Epidemiology, & Informatics, University of Pennsylvania, Philadelphia, PA USA
PhDAmy S. Clark
2Division of Hematology and Oncology, University of Pennsylvania, Philadelphia, PA USA
MD MSCEDaniel J. Lee
4Division of Urology, University of Pennsylvania, Philadelphia, PA USA
MDGaurav Goyal
5Division of Hematology and Oncology, University of Alabama at Birmingham, Birmingham, AL USA
MDGabrielle B. Rocque
5Division of Hematology and Oncology, University of Alabama at Birmingham, Birmingham, AL USA
MD MSPHEfrat Dotan
6Department of Medical Oncology, Fox Chase Cancer Center, Philadelphia, PA USA
MDDaniel M. Geynisman
6Department of Medical Oncology, Fox Chase Cancer Center, Philadelphia, PA USA
MDPooja Phull
6Department of Medical Oncology, Fox Chase Cancer Center, Philadelphia, PA USA
MDPhilippe E. Spiess
7Department of Genitourinary Oncology, Moffitt Cancer Center, Tampa, FL USA
MD MS FRCS(C) FACSRoger Y. Kim
8Division of Pulmonary, Allergy, and Critical Care, University of Pennsylvania, Philadelphia, PA USA
MDAmy J. Davidoff
9National Cancer Institute, Bethesda, MD USA
PhD MSCary P. Gross
10Cancer Outcomes Public Policy & Effectiveness Research, Yale School of Medicine, New Haven, CT USA
MDNatalia Neparidze
10Cancer Outcomes Public Policy & Effectiveness Research, Yale School of Medicine, New Haven, CT USA
MDRebecca A. Miksad
11Flatiron Health, New York, NY USA
MD MPHGregory S. Calip
11Flatiron Health, New York, NY USA
PharmD MPH PhDCaleb M. Hearn
1Department of Medical Ethics and Health Policy, University of Pennsylvania, Philadelphia, PA USA
MPHWill Ferrell
1Department of Medical Ethics and Health Policy, University of Pennsylvania, Philadelphia, PA USA
MPHLawrence N. Shulman
2Division of Hematology and Oncology, University of Pennsylvania, Philadelphia, PA USA
MDRonac Mamtani
2Division of Hematology and Oncology, University of Pennsylvania, Philadelphia, PA USA
MD MSCERebecca A. Hubbard
3Department of Biostatistics, Epidemiology, & Informatics, University of Pennsylvania, Philadelphia, PA USA
PhDData Availability
All de-identified data generated or analyzed during this study is available upon request.
Posted September 23, 2021.
Impact of the COVID-19 pandemic on treatment patterns for US patients with metastatic solid cancer
Ravi B. Parikh, Samuel U. Takvorian, Daniel Vader, E. Paul Wileyto, Amy S. Clark, Daniel J. Lee, Gaurav Goyal, Gabrielle B. Rocque, Efrat Dotan, Daniel M. Geynisman, Pooja Phull, Philippe E. Spiess, Roger Y. Kim, Amy J. Davidoff, Cary P. Gross, Natalia Neparidze, Rebecca A. Miksad, Gregory S. Calip, Caleb M. Hearn, Will Ferrell, Lawrence N. Shulman, Ronac Mamtani, Rebecca A. Hubbard, for the PRACTICE Investigators
medRxiv 2021.09.22.21263964; doi: https://doi.org/10.1101/2021.09.22.21263964
Impact of the COVID-19 pandemic on treatment patterns for US patients with metastatic solid cancer
Ravi B. Parikh, Samuel U. Takvorian, Daniel Vader, E. Paul Wileyto, Amy S. Clark, Daniel J. Lee, Gaurav Goyal, Gabrielle B. Rocque, Efrat Dotan, Daniel M. Geynisman, Pooja Phull, Philippe E. Spiess, Roger Y. Kim, Amy J. Davidoff, Cary P. Gross, Natalia Neparidze, Rebecca A. Miksad, Gregory S. Calip, Caleb M. Hearn, Will Ferrell, Lawrence N. Shulman, Ronac Mamtani, Rebecca A. Hubbard, for the PRACTICE Investigators
medRxiv 2021.09.22.21263964; doi: https://doi.org/10.1101/2021.09.22.21263964
Subject Area
Subject Areas
- Addiction Medicine (371)
- Allergy and Immunology (689)
- Anesthesia (184)
- Cardiovascular Medicine (2754)
- Dermatology (235)
- Emergency Medicine (414)
- Epidemiology (12403)
- Forensic Medicine (10)
- Gastroenterology (784)
- Genetic and Genomic Medicine (4261)
- Geriatric Medicine (396)
- Health Economics (699)
- Health Informatics (2758)
- Health Policy (1019)
- Hematology (369)
- HIV/AIDS (880)
- Medical Education (404)
- Medical Ethics (112)
- Nephrology (453)
- Neurology (4043)
- Nursing (216)
- Nutrition (599)
- Oncology (2128)
- Ophthalmology (604)
- Orthopedics (251)
- Otolaryngology (313)
- Pain Medicine (256)
- Palliative Medicine (77)
- Pathology (478)
- Pediatrics (1149)
- Primary Care Research (470)
- Public and Global Health (6653)
- Radiology and Imaging (1446)
- Respiratory Medicine (886)
- Rheumatology (421)
- Sports Medicine (353)
- Surgery (464)
- Toxicology (57)
- Transplantation (192)
- Urology (171)